EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma

Luca Giacchi iD, Elisa Pucci iD, Nadia Rucci

Cancers · 09.02.2026 · 18 (4) · 561

DOI: 10.3390/cancers18040561 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 09.02.2026. Verfasst von Luca Giacchi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma remains a highly aggressive malignancy with limited therapeutic progress and poor outcomes, particularly in metastatic or recurrent cases. Conventional treatment approaches, primarily based on surgery and high-dose chemotherapy, are hindered by significant drawbacks, including severe toxicity, high relapse rates, and drug resistance, underscoring the inadequacy of current standard approaches. This review examines emerging advances in precision medicine and drug discovery, including targeted inhibitors, immunomodulatory agents, combination treatments, and advanced biomaterials, that promise to transform osteosarcoma care. Recent advances, such as combinations of immune checkpoint inhibitors with novel agents or nanoparticle-based drug delivery systems, as well as CRISPR-Cas9 gene-editing applications, offer new strategies to overcome the inherent challenges of conventional therapies. In addition, cutting-edge research leveraging multi-omics analyses and digital pathology is refining our understanding of the tumour microenvironment, paving the way for more individualised treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

chemoresistancechemotherapyimmunotherapylung metastasesnanotechnologyosteosarcoma

Autor:innen und Institutionen

  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

ORCID-Profile: Luca Giacchi, Elisa Pucci

Förderung

  • AIRC

Zitieren

APA

Giacchi, L., Pucci, E., & Rucci, N. (2026). From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma. Cancers, 18(4), 561. https://doi.org/10.3390/cancers18040561

Vancouver

Giacchi L, Pucci E, Rucci N. From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma. Cancers. 2026;18(4):561. doi:10.3390/cancers18040561

BibTeX
@article{Giacchi2026,
  author = {Giacchi, Luca and Pucci, Elisa and Rucci, Nadia},
  title = {From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {561},
  doi = {10.3390/cancers18040561}
}
Kostenlos starten →